Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Pain Therapeutics (PTIE)

4.05 +0.05 (+1.25%)

6/26/2017  3:59pm

Open:

4.05

Pre. Close:

4.00

High:

4.11

Low:

4.00

Volume:

21,470

Market Cap:

26.69M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.13 - 4.24

4.24 - 4.34

Low:

3.81 - 3.89

3.89 - 3.96

Close:

3.93 - 4.06

4.06 - 4.18

Technical analysis  (as of: 2017-06-26 11:35:57 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 5.31     One year: 6.21

Support:

Support1: 3.83    Support2: 3.39

Resistance:

Resistance1: 4.55    Resistance2: 5.31

Pivot:

3.97

Moving Averages:

MA(5): 4.12     MA(20): 3.97

MA(100): 4.76     MA(250): 7.86

MACD:

MACD(12,26): -0.11     Signal(12,26,9): -0.18

%K %D:

%K(14,3): 71.38     %D(3): 75.28

RSI:

RSI(14): 45.66

52-Week:

High: 21.00  Low: 3.39  Change(%): -71.5

Average Vol(K):

3-Month: 82  10-Days 34

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PTIE has closed below upper band by 40.0%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTIE's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 21 Mar 2017 09:41:16 GMT
Pain Therapeutics' Remoxy ER Secures FDA Regulatory Guidance (PTIE, EGLT)

Mon, 26 Jun 2017 21:56:15 GMT
Pain Therapeutics, Inc. (NasdaqGS:PTIE) Value Composite Score Update

Tue, 27 Jun 2017 10:18:45 GMT
$0.00 EPS Expected for Pain Therapeutics, Inc. (PTIE), Cobham plc (LON:COB ...

Tue, 20 Jun 2017 10:07:30 GMT
Breakfast Technical Briefing on Biotech Stocks -- Opko Health, Pain ...

Mon, 19 Jun 2017 14:40:04 GMT
Pain Therapeutics, Inc. (PTIE) EPS Estimated At $0.00

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

6.59

Shares Float (M)

4.92

% Held by Insiders

23.38

% Held by Institutions

45.30

Shares Short (K)

418

Shares Short Prior Month (K)

407

Stock Financials

EPS

-1.840

EPS Est. Current Year

1.290

EPS Est. Next Year

-3.090

EPS Est. Next Quarter

-0.550

Forward EPS

-3.085

Book Value (p.s.)

2.540

PEG Ratio

0.03

Profit Margin

Operating Margin

Return on Assets (ttm)

-32.2

Return on Equity (ttm)

-56.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.795

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.54

Levered Free Cash Flow (M)

-6.28

FoxReading.com

Valuation

P/E

-2.20

P/E Growth Ratio

0.01

P/BV

1.59

P/S

P/CF

-2.53

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-12-24

Ex-Dividend Date

2012-12-13

Forward Dividend

Last Split Date

2017-05-10

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.